{"doi":"10.1194/jlr.m400256-jlr200","title":"Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis","abstract":null,"journal":"Journal of Lipid Research","year":2005,"id":614167,"datarank":0.4493598410330987,"base_score":2.995732273553991,"endowment":2.995732273553991,"self_citation_contribution":0.4493598410330987,"citation_network_contribution":0.0,"self_endowment_contribution":0.4493598410330987,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":19,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":139869,"name":"Gerald Salen","orcid":null,"position":1,"is_corresponding":false},{"id":1582593,"name":"Yasushi Matsuzaki","orcid":null,"position":2,"is_corresponding":false},{"id":139873,"name":"Ashok K. Batta","orcid":null,"position":3,"is_corresponding":false},{"id":139871,"name":"Guorong Xu","orcid":null,"position":4,"is_corresponding":false},{"id":1582594,"name":"Takeshi Hirayama","orcid":null,"position":5,"is_corresponding":false},{"id":1582595,"name":"G. Stephen Tint","orcid":null,"position":6,"is_corresponding":false},{"id":1582596,"name":"Mikio Doy","orcid":null,"position":7,"is_corresponding":false},{"id":139874,"name":"Sarah Shefer","orcid":null,"position":8,"is_corresponding":false},{"id":139868,"name":"Akira Honda","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis","abstract":"Cerebrotendinous xanthomatosis (CTX), sterol 27-hydroxylase (CYP27A1) deficiency, is associated with markedly reduced chenodeoxycholic acid (CDCA), the most powerful activating ligand for farnesoid X receptor (FXR). We investigated the effects of reduced CDCA on FXR target genes in humans. Liver specimens from an untreated CTX patient and 10 control subjects were studied. In the patient, hepatic CDCA concentration was markedly reduced but the bile alcohol level exceeded CDCA levels in control subjects (73.5 vs. 37.8 +/- 6.2 nmol/g liver). Cholesterol 7alpha-hydroxylase (CYP7A1) and Na+/taurocholate-cotransporting polypeptide (NTCP) were upregulated 84- and 8-fold, respectively. However, small heterodimer partner (SHP) and bile salt export pump were normally expressed. Marked CYP7A1 induction with normal SHP expression was not explained by the regulation of liver X receptor alpha (LXRalpha) or pregnane X receptor. However, another nuclear receptor, hepatocyte nuclear factor 4alpha (HNF4alpha), was induced 2.9-fold in CTX, which was associated with enhanced mRNA levels of HNF4alpha target genes, CYP7A1, 7alpha-hydroxy-4-cholesten-3-one 12alpha-hydroxylase, CYP27A1, and NTCP. In conclusion, the coordinate regulation of FXR target genes was lost in CTX. The mechanism of the disruption may be explained by a normally stimulated FXR pathway attributable to markedly increased bile alcohols with activation of HNF4alpha caused by reduced bile acids in CTX liver.","is_dataset_classified":null,"base_score":2.995732273553991,"endowment":2.995732273553991,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"15576845","pmcid":null,"openalex_id":"https://openalex.org/W2149495179","authors":[],"funders":[{"funder_name":"NIDDK NIH HHS","grant_id":"DK-26756","title":null},{"funder_name":"NIDDK NIH HHS","grant_id":"DK-56830","title":null}],"total_grants":2,"fwci":1.0242,"citation_percentile":0.76332114,"influential_citations":0,"citation_trend":[{"year":2012,"count":2},{"year":2013,"count":1},{"year":2016,"count":2},{"year":2023,"count":1},{"year":2025,"count":2},{"year":2026,"count":1}],"oa_status":"hybrid","license":"cc-by","oa_locations":[{"url":"https://doi.org/10.1194/jlr.m400256-jlr200","host_type":"journal"},{"url":"https://doi.org/10.1194/jlr.m400256-jlr200","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0022227520340621?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0022227520340621?httpAccept=text/plain","host_type":"publisher"},{"url":"https://syndication.highwire.org/content/doi/10.1194/jlr.M400256-JLR200","host_type":"publisher"},{"url":"https://pubmed.ncbi.nlm.nih.gov/15576845","host_type":"repository"},{"url":"https://doaj.org/article/93d1bd6384294b5fade933663ec32d13","host_type":"repository"}],"fields_of_study":["Drug Transport and Resistance Mechanisms","Cholesterol and Lipid Metabolism","Pharmacogenetics and Drug Metabolism","ATP Binding Cassette Transporter, Subfamily B, Member 11","ATP-Binding Cassette Transporters","Adult","Alcohols","Bile Acids and Salts","Case-Control Studies","Chenodeoxycholic Acid","Cholestanetriol 26-Monooxygenase","Cholestanols","Cholesterol 7-alpha-Hydroxylase","DNA Primers","DNA-Binding Proteins","Female","Gene Expression Regulation","Hepatocyte Nuclear Factor 4","Humans","Liver","Liver X Receptors","Male","Membrane Transport Proteins","Middle Aged","Models, Biological","Organic Anion Transporters, Sodium-Dependent","Orphan Nuclear Receptors","Phosphoproteins","Pregnane X Receptor","Protein Binding","RNA, Messenger","Receptors, Cytoplasmic and Nuclear","Receptors, Steroid","Steroid Hydroxylases","Symporters","Transcription Factors","Up-Regulation","Xanthomatosis, Cerebrotendinous","Receptor, Farnesoid X-Activated"],"mesh_terms":["Liver X Receptors","ATP Binding Cassette Transporter, Subfamily B, Member 11","Pregnane X Receptor","Receptor, Farnesoid X-Activated","Adult","Alcohols","Bile Acids and Salts","Chenodeoxycholic Acid","Cholestanols","Cholesterol 7-alpha-Hydroxylase","DNA-Binding Proteins","Female","Gene Expression Regulation","Humans","Liver","Male","Middle Aged","Models, Biological","Phosphoproteins","Protein Binding","Receptors, Steroid","RNA, Messenger","Steroid Hydroxylases","Transcription Factors","Up-Regulation","Case-Control Studies","DNA Primers","Receptors, Cytoplasmic and Nuclear","ATP-Binding Cassette Transporters","Xanthomatosis, Cerebrotendinous","Membrane Transport Proteins","Symporters","Organic Anion Transporters, Sodium-Dependent","Hepatocyte Nuclear Factor 4","Cholestanetriol 26-Monooxygenase","Orphan Nuclear Receptors"],"keywords":["Farnesoid X receptor","Cerebrotendinous Xanthomatosis","Cholesterol 7 alpha-hydroxylase","Chenodeoxycholic acid","CYP27A1","Pregnane X receptor","Small heterodimer partner","Liver X receptor alpha","Internal medicine","Nuclear receptor","Bile acid","G protein-coupled bile acid receptor","Endocrinology","Chemistry","Liver X receptor","Constitutive androstane receptor","Liver receptor homolog-1","CYP8B1","Lithocholic acid","Biology","Cholesterol","Biochemistry","Medicine","Gene","Transcription factor"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-02T11:13:54.824570Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}